Cheryl Schendel

Cheryl Schendel is a Senior Research Associate II at AnaptysBio since November 2020, bringing extensive experience in research and quality control within the biotechnology and biomedical fields. Prior to this role, Cheryl worked as a Quality Control Associate III at Fate Therapeutics Inc from September 2015 to 2020, where responsibilities included quality testing of cell products and cell line maintenance in a GMP environment. Cheryl also has experience as a Research Associate II at both Fate Therapeutics and Intrexon Corporation, contributing to translational research and 3D cell culture methodologies. Earlier positions include roles at eBioscience, UC San Diego, and St. Joseph's Hospital, focusing on immunological research, stroke therapy, and neuro-oncology. Cheryl holds a B.S. in Biology from Arizona State University.